Folger Nolan Fleming Douglas Capital Management’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $3.78M | Hold |
|
|||||
2025
Q1 | $4.01M | Sell |
|
|||||
2024
Q4 | $3.79M | Sell |
|
|||||
2024
Q3 | $4.54M | Sell |
|
|||||
2024
Q2 | $4.68M | Sell |
|
|||||
2024
Q1 | $4.05M | Sell |
|
|||||
2023
Q4 | $3.04M | Sell |
|
|||||
2023
Q3 | $2.83M | Sell |
|
|||||
2023
Q2 | $2.49M | Sell |
|
|||||
2023
Q1 | $1.83M | Hold |
|
|||||
2022
Q4 | $1.95M | Buy |
|
|||||
2022
Q3 | $1.56M | Hold |
|
|||||
2022
Q2 | $1.56M | Hold |
|
|||||
2022
Q1 | $1.38M | Hold |
|
|||||
2021
Q4 | $1.33M | Hold |
|
|||||
2021
Q3 | $1.11M | Hold |
|
|||||
2021
Q2 | $1.11M | Hold |
|
|||||
2021
Q1 | $901K | Hold |
|
|||||
2020
Q4 | $814K | Hold |
|
|||||
2020
Q3 | $714K | Hold |
|
|||||
2020
Q2 | $792K | Hold |
|
|||||
2020
Q1 | $669K | Sell |
|
|||||
2019
Q4 | $635K | Hold |
|
|||||
2019
Q3 | $540K | Buy |
|
|||||
2019
Q2 | $534K | Hold |
|
|||||
2019
Q1 | $626K | Hold |
|
|||||
2018
Q4 | $558K | Hold |
|
|||||
2018
Q3 | $517K | Hold |
|
|||||
2018
Q2 | $411K | Hold |
|
|||||
2018
Q1 | $373K | Hold |
|
|||||
2017
Q4 | $407K | Buy |
|
|||||
2017
Q3 | $348K | Hold |
|
|||||
2017
Q2 | $335K | Hold |
|
|||||
2017
Q1 | $342K | Hold |
|
|||||
2016
Q4 | $337K | Hold |
|
|||||
2016
Q3 | $337K | Hold |
|
|||||
2016
Q2 | $320K | Hold |
|
|||||
2016
Q1 | $293K | Hold |
|
|||||
2015
Q4 | $343K | Hold |
|
|||||
2015
Q3 | $340K | Hold |
|
|||||
2015
Q2 | $339K | Hold |
|
|||||
2015
Q1 | $295K | Hold |
|
|||||
2014
Q4 | $281K | Buy |
|
|||||
2014
Q3 | $212K | Hold |
|
|||||
2014
Q2 | $203K | Buy |
|